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In the 21st century, nanotechnology has been emerging as a very 
promising field, with numerous applications in distinct areas, such as 
textiles, food agriculture, environment, electronics and in the 
biomedical field. Among the different categories of nanomaterials, 
zeolites are a very important class of inorganic materials that have 
been used in a wide range of applications. In the current work, we used 
zeolite NaY as host to incorporate silver ions and the antineoplastic 
drug 5-Fluorouracil (5-FU) for microbial infections and non-
melanoma skin cancer treatment, respectively. Both situations present 
a major threat to public health: microbial infections due to their 
increasing resistance to antibiotics and cancer because of the difficulty 
of an efficient treatment especially when the disease has progressed 
considerably. So, since zeolites have a range of structural and physical 
properties that make them suitable for therapeutic delivery systems, 
they could be interesting candidates for this purpose. Our goal is to 
create an efficient and biocompatible dual topical delivery system with 
zeolites and, this way, combine the antimicrobial and the 
antineoplastic activity in the same formulation.  
Introduction 
Zeolites are microporous crystalline nanomaterials that contain 
alkaline metal ions (that can be readily exchanged by other 
cations in solution) and water molecules within their structure 
and are composed by silicon, aluminum and oxygen. Their 3D 
framework of SiO4 and AlO4 tetrahedra results in a uniform 
network of nano-channels and pores. Water molecules can be 
easily removed upon heating, resulting in a high surface area and 
an accessible pore volume that allows diffusion of the molecules 
to the interior of the zeolite particle [1-3]. The number of areas 
utilizing zeolites has grown tremendously and several studies 
have reported its use in the industrial sector, as detergent water 
softeners, as food additives, as adsorbents for wastewater 
treatment [4-5], as catalysts in industrial processes and in the 
biomedical field, such as magnetic resonance imaging, wound 
treatment, as drug delivery systems (DDS) and as antimicrobial 
agent (by incorporating cations with antimicrobial action) [6-8]. 
In this work, we explored and combined these last two 
applications loading zeolite NaY with silver ions by ion 
exchange followed by loading with 5-Fluorouracil (5-FU), 
originating a dual biocompatible nanomaterial system, (Ag/5-
FU)Y as DDS for topical delivery. 
 
Methods  
1. Preparation of DDS. A solution of 0.01 M of silver(I) nitrate 
(Sigma-Aldrich) was added to the zeolite NaY (Zeolyst 
International) and the resulting suspension was maintained 
under constant stirring at 300 rpm for 24 h at room temperature. 
Suspension was then filtered and washed with deionized water 
and dried overnight at 60 ºC to obtain the AgY. The resulting 
sample was calcined at 350 ºC for 4 h. Loading of the drug 5-FU 
into the zeolitic structure was achieved by adding 200 mg of 
AgY to a solution of 5-FU (0.023 mM) in acetone (80 % 
acetone/20 % water; v/v). The suspension was kept under 
stirring at room temperature for 48 h. The resulting mixture was 
filtered and washed and the DDS ((Ag/5-FU)Y) was dried at 60 
ºC for 12 h to evaporate the solvent. Na(5-FU)Y was prepared 
as described in [2].  
2. Evaluation of antimicrobial activity. To evaluate the 
antimicrobial activity of the prepared samples, several bacterial 
strains which are known to be capable of triggering several 
infections (including skin infections) and therefore compromise 
human health, were selected as predictive models. 5 µL drops of 
each inoculum (bacterial cultures at OD  0.4–0.6) were placed 
on top of agar plates containing the culture medium 
supplemented with zeolite nanomaterials. Assays were 
performed in the presence of 0.2, 0.5, 1 and 2 mg/mL of each 
zeolite sample. Minimum inhibitory concentration (MIC), 
defined as the lowest concentrations that prevent bacterial 
growth, were determined for each pair sample/bacterial strain 
tested.  
3. Cell viability assays. Cell viability studies were performed 
using a human skin cancer cell line, A375. The cell line was 
routinely cultured in DMEM, supplemented with 10 % (v/v) 
Fetal Bovine Serum and 1 % (v/v) penicillin–streptomycin and 
maintained in a 5 % CO2 humidified atmosphere. Cells were 
subcultured every 2 to 3 days (approximately when they reached 
80% confluence) to ensure their proper growth and health. To 
evaluate the effect of zeolite-mediated cytotoxicity and cell 
proliferation in vitro, Sulforhodamine B (SRB) colorimetric 
assay was performed. 
 
Results  
We observed that bacterial growth was unaffected by the 
presence of parent zeolite, NaY, regardless of the concentration 
tested, meaning that the zeolite itself revealed no antibacterial 
effects. However, AgY exhibited antibacterial activity against 
all the bacterial strains tested and no viable bacterial cells were 
detected in the presence of 1 mg/mL of AgY, proving that the 
introduction of silver ions in the zeolitic structure gives the 
antibacterial properties. The DDS (Ag/5-FU)Y also exhibited 
inhibitory effects on bacterial growth, showing that the zeolite 
maintains its antibacterial capacity in the presence of both 
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agents, so the presence of 5-FU does not interfere with the 
release and action of silver ions. Interestingly, the MIC values 
obtained with (Ag/5-FU)Y were lower than the values for AgY, 
meaning that the hybrid system exhibited enhanced antibacterial 
properties which may be caused by the combined action of 5-FU 
and silver ions (Table 1). 
 
Table 1. MIC values for NaY, AgY and (Ag/5-FU)Y against 
each of the tested indicator bacterial strains 
 
P. acnes - Propionibacterium acnes, MRSA - Methicillin-resistant 
Staphylococcus aureus, S. aureus - Staphylococcus aureus, E. coli - 
Escherichia coli and P. aeruginosa - Pseudomonas aeruginosa 
 
Regarding the cancer cell viability tests (Figure 1), NaY did not 
interfere with the cell viability in the tested range of sample 
concentrations and throughout the entire period of exposure of 
the cells to the samples (up to 72 h), indicating its suitability as 
a drug delivery system for this type of cancer cells. (Ag/5-FU)Y 
caused a very accentuated decrease in cell viability. Similarly, 
AgY, which does not contain the antineoplastic drug 5-FU, also 
showed the same behavior, indicating that silver ions are highly 
cytotoxic to A375 cells. This way, both agents incorporated in 
the zeolite structure, silver ions and 5-FU, have an active role on 
the decrease of cell viability.   
 
Figure 1. Effect of NaY (blue), AgY (green), Na(5-FU)Y 
(purple) and (Ag/5-FU)Y (red) on A375 human cells viability. 
 
Conclusions 
(Ag/5-FU)Y showed good antimicrobial properties, and in some 
cases with lower MIC values than the sample with only silver 
ions, suggesting that 5-FU itself has some antibacterial effect. 
Moreover, the DDS proved to be highly cytotoxic to A375 cells, 
an effect that is not only the result of 5-FU action but is also due 
to the presence of Ag+ ions. These results highlight the great 
potential of the dual nanomaterial system and, with further work, 
it could be eventually incorporated into a biocompatible cream 
to be used for topical delivery, and this way combine the 
advantageous effects of the antimicrobial and antineoplastic 
activity in the same formulation.
Acknowledgements 
This work has been developed under the scope of the project NORTE-01-0145-FEDER-000013 and the project BioTecNorte (operation 
NORTE-01-0145-FEDER-000004), supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the 
Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). This work has been funded by 
FEDER funds, through the Competitiveness Factors Operational Programme (COMPETE), under Project POCI-01-0145-FEDER-
006958 and by National funds, through the Foundation for Science and Technology (FCT), under the scope of the projects: 
PTDC/AAGTEC/5269/2014, Centre of Chemistry (UID/QUI/00686/2013 and UID/QUI/0686/2016), CITAB´s UID/AGR/04033/2013 
and ICVS/3B’s POCI-01-0145-FEDER-007038. 
 
References 
[1] L. Ferreira, et al., Microporous and Mesoporous Materials, 160 (2012) 126-132. 
[2] N. Vilaça, et al., Colloids and Surfaces B: Biointerfaces, 112 (2013) 237-244. 
[3] R. Amorim, et al., Journal of Physical Chemistry C, 116 (2012) 25642–25650 
[4] C. Tzia, A. Zorpas, A. Handbook of natural zeolites. 551 Bentham Science Publishers. (2012) 601-651. 
[5] E.M. Flanigen, R.W. Broach, S.T. Wilson, Wiley-VCH Verlag GmbH & Co. KGaA. (2010) 1-26.  
[6] L. Ferreira, et al., Colloids and Surfaces B: Biointerfaces, 142 (2016) 141-147. 
[7] S.P. Chandran, et al., Journal of Cancer Research and Practice, 4(2) (2017) 45-48. 
[8] M. Spanakis, et al., Nanomedicine: Nanotechnology, Biology and Medicine, 10 (2014) 197-205.  
 
  
CHEMPOR 2018
299
